Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2000
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2364659A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1043998A1 USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043963A1 Osteopontin-based compositions for enhancing bone repair
10/18/2000CN1270589A Epothilone derivatives
10/18/2000CN1270516A Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1270057A Medical wine and ointment for treating bone fracture and injury
10/18/2000CN1270055A Medical capsule for treating bone rheumatism and preparing process
10/18/2000CN1270053A Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/17/2000US6133479 Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/17/2000US6133458 Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, and methods
10/17/2000US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea
10/17/2000US6133288 2,8-di(hydroxy)-5-((2-piperidin-1-yl)ethyoxy-1,4-phenylene)-)-5h -benzo-(e)naphtho(1,2-c)pyran; post-menopausal syndrome, osteoporosis, cardiovascular disorders; uterine fibrosis, endometriosis, and aortal smooth muscle cell proliferation
10/17/2000US6133283 Mono- or polyenic carboxylic acid derivatives
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133249 Phospholipid and propylene glycol based lubricant
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
10/17/2000CA2024694C Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059897A2 Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059864A1 Lta4 hydrolase inhibitors
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059508A1 Tolperison-containing, pharmaceutical preparation for oral administration
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059495A1 (e)-styryl sulfone anticancer agents
10/12/2000WO2000059485A2 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
10/12/2000WO2000059484A2 Use of arylalkanoylpyridazines
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000WO2000020449A3 MODIFIED TGF-β SUPERFAMILY PROTEINS
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000DE19915364A1 Verwendung von Arylalkanoylpyridazinen Use of Arylalkanoylpyridazinen
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368493A1 Lta4 hydrolase inhibitors
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/11/2000EP1043317A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042456A1 Human nucleotide pyrophosphohydrolase-2
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042301A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
10/11/2000EP1041989A1 Novel cycloalkenyl substituted compounds
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds
10/11/2000CN1269786A Aromatic C16-C20 substituted tetrahydro prostaglandins useful as EP agonists
10/11/2000CN1269785A Aromatic C16-C20 substituted tetrahydro prostaglandius useful as EP agonists
10/11/2000CN1269784A Aromatic C16-C20 substituted tetrahydro prostagladins useful as FP agonists
10/11/2000CN1269726A Fracture healing using PTHrp analogs
10/11/2000CN1269721A Method for increasing bone volumn using non-naturally-occuring EP selective agonists
10/11/2000CN1269720A Method of increasing bone volume
10/11/2000CN1269242A Osteogenic growth peptide medicine composite and its preparation and application
10/11/2000CN1269217A Bagged blood circulation-activating and obstruction-dredging granule and its preparation
10/11/2000CN1269216A Tendon injure treating spray and its preparation
10/11/2000CN1269213A The active part of golden pheasant as one Chinese medicine material and its application in preparing medicinal composite
10/11/2000CN1057228C Ointment for trauma and fracture and its preparation method thereof
10/11/2000CN1057207C Composition for treating osteoporosis
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130226 Immunotherapeutic agents
10/10/2000CA2056421C Agent against autoimmune diseases
1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 820